FOSUN 复星

Artistic Director Peter Copping continued the captivating work of rebuilding and revitalising France’s oldest couture house at the LANVIN Summer 2026 show in Paris on Tuesday. The refreshed interpretation of the house’s iconic blue embodies “ultimate chic,” redefined with a timeless elegance. #LANVINS26 #LANVIN #ParisFashionWeek

Jason Zhu, CEO of Henlius , shared the company’s latest progress and reaffirmed Henlius’ commitment to addressing unmet medical needs through innovation.

With this latest successful equity capital injection from IFC - International Finance Corporation, Asian Development Bank (ADB) and Fosun Pharma, Fosun United Health Insurance will further increase its resource investment, aiming to enhance the customer experience across both products and services.

For 75 years, Wolford has dressed women of all ages and backgrounds with its pioneering, comfortable stockings, dresses, and bodysuits. As Austria’s iconic brand celebrates its milestone anniversary, Creative Director Nao Takekoshi shares a bold vision with WWD “from making great products to becoming a brand with a purpose.” Aslo, Deputy CEO Marco Pozzo unveils the company’s plan for revitalization and growth. #thethreadofattitude #wolford75

Fosun is committed to advancing health insurance solutions that support communities across emerging markets. We value the meaningful dialogue and collaboration, as we work together for a more sustainable insurance landscape in this rapidly changing environment. #HealthInsurance

In the first half of 2025, Fosun achieved breakthroughs in key industries where it holds competitive advantages — particularly in the biopharmaceutical sector. Fosun also continues to strengthen its global operational capabilities, with overseas revenue reaching RMB 46.67 billion during the reporting period, accounting for 53% of the Group’s total revenue. Take a look at the video for an overview of Fosun’s performance highlights.

Fosun International (HKEX: 00656) announced its 2025 interim results, reporting total revenue of RMB87.28 billion and profit attributable to owners of RMB661.2 million in the first half. The Group strengthened its focus on #innovation, with its innovative drug business entering a rapid growth phase, while #globalization efforts drove steady overseas expansion. Fosun also advanced AI applications and pursued business streamlining, further optimizing its asset structure and reinforcing its financial position. 📊 Explore the highlights through the 9 performance graphs below.

Henlius is committed to making breast cancer treatments more accessible worldwide. "After receiving a Chinese #biopharma treatment, I regained my energy --- even doing things I thought I’d lost forever," says Rita, a breast cancer survivor, as she shares her journey of treatment and recovery. In July 2025, Henlius celebrates the fifth anniversary of the global approval of its blockbuster #breastcancer therapy, HANQUYOU (trastuzumab, trade name: HERCESSI™ in the U.S., Zercepac® in Europe). As the first "China-developed" monoclonal antibody (mAb) biosimilar approved in China, the EU, and the U.S., HANQUYOU has been launched in over 50 countries and regions worldwide, with more than 7.5 million units shipped globally. https://lnkd.in/enRmEfWS

Easun's Global Hi-Po Program BLT 2025: Shanghai Chapter Successfully Concludes, Launching the Next Generation of Global Leaders The successful completion of the Shanghai chapter of Easun Technology's Brilliant Leader for Tomorrow (BLT) 2025 marks a major milestone in building a global talent pipeline. From over 3,000 global candidates, 12 future leaders from China, Germany, the US, and Mexico were selected for this two-year cross-continental journey, based on the "70-20-10" development model: 70% hands-on projects, 20% executive mentorship, and 10% structured learning. The Shanghai module focused on organizational development, featuring leadership workshops, strategic dialogues with Fosun, and a deep dive into Easun's headquarters, helping participants align with the company's culture and vision. Upcoming modules will expand the program's global reach: Mexico will emphasize cross-border collaboration in emerging markets, while the Germany chapter will hone strategic decision-making. Together, these experiences are shaping a new generation of leaders with global vision and execution power — injecting transformative leadership into the future. #LeadershipDevelopment #CrossCulturalLeadership #BLT2025

S&P Global Ratings has assigned ‘A’ long-term Issuer Credit and Financial Strength Ratings, with a stable outlook, to Fidelidade – Companhia de Seguros, S.A. and its reinsurer, Fidelidade RE. S&P Global expects Fidelidade to maintain strong capital, solid profitability, and market leadership both in Portugal and internationally over the next two years. This is Fidelidade’s second ‘A’ rating in a short period. In September 2024, Fitch Ratings upgraded Fidelidade to A+ (IFS) and A (IDR), both with a Stable Outlook — the highest rating ever given by Fitch to a Portuguese company at the time. https://lnkd.in/e4Df3Stb